Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1159/000509368

http://scihub22266oqcxt.onion/10.1159/000509368
suck pdf from google scholar
32544911!7360494!32544911
unlimited free pdf from europmc32544911    free
PDF from PMC    free
html from PMC    free
PDF vom PMID32544911 :   free
PDF vom PMID32544911  :  Publisher

suck abstract from ncbi

pmid32544911
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Strategies to Prevent SARS-CoV-2-Mediated Eosinophilic Disease in Association with COVID-19 Vaccination and Infection #MMPMID32544911
  • Simon HU; Karaulov AV; Bachmann MF
  • Int Arch Allergy Immunol 2020[]; 181 (8): 624-628 PMID32544911show ga
  • A vaccine to protect against COVID-19 is urgently needed. Such a vaccine should efficiently induce high-affinity neutralizing antibodies which neutralize SARS-CoV-2, the cause of COVID-19. However, there is a concern regarding both vaccine-induced eosinophilic lung disease and eosinophil-associated Th2 immunopotentiation following infection after vaccination. Here, we review the anticipated characteristics of a COVID-19 vaccine to avoid vaccine-associated eosinophil immunopathology.
  • |Antibodies, Neutralizing/biosynthesis[MESH]
  • |Betacoronavirus/*immunology[MESH]
  • |Coronavirus Infections/immunology/*prevention & control[MESH]
  • |Eosinophils/*physiology[MESH]
  • |Humans[MESH]
  • |Pandemics/*prevention & control[MESH]
  • |Pneumonia, Viral/*prevention & control[MESH]
  • |Th2 Cells/*immunology[MESH]
  • |Vaccination/*adverse effects[MESH]
  • |Viral Vaccines/*adverse effects/immunology[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    624 8.181 2020